Exiqon's Q3 Revenues Increase 30 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exiqon reported today that its third-quarter revenues jumped 30 percent year over year.

The Danish miRNA research products and diagnostics firm brought in total revenues of DKK 27.1 million ($5 million) for the quarter ended Sept. 30, compared to DKK 20.9 million for the third quarter of 2010. It said that its research product sales grew 33 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.